orion pharma (uk) limited

Live MatureLargeHealthy

orion pharma (uk) limited Company Information

Share ORION PHARMA (UK) LIMITED

Company Number

02281057

Directors

Olli Houtari

Aino Hurme

View All

Shareholders

orion corporation

Group Structure

View All

Industry

Wholesale of pharmaceutical goods

 

Registered Address

the scalpel, 18th floor, 52 lime street, london, EC3M 7AF

orion pharma (uk) limited Estimated Valuation

£24.8m

Pomanda estimates the enterprise value of ORION PHARMA (UK) LIMITED at £24.8m based on a Turnover of £25.4m and 0.98x industry multiple (adjusted for size and gross margin).

orion pharma (uk) limited Estimated Valuation

£14.2m

Pomanda estimates the enterprise value of ORION PHARMA (UK) LIMITED at £14.2m based on an EBITDA of £1.5m and a 9.71x industry multiple (adjusted for size and gross margin).

orion pharma (uk) limited Estimated Valuation

£26m

Pomanda estimates the enterprise value of ORION PHARMA (UK) LIMITED at £26m based on Net Assets of £13.6m and 1.91x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Orion Pharma (uk) Limited Overview

Orion Pharma (uk) Limited is a live company located in london, EC3M 7AF with a Companies House number of 02281057. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in July 1988, it's largest shareholder is orion corporation with a 100% stake. Orion Pharma (uk) Limited is a mature, large sized company, Pomanda has estimated its turnover at £25.4m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Orion Pharma (uk) Limited Health Check

Pomanda's financial health check has awarded Orion Pharma (Uk) Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

6 Strong

positive_score

1 Regular

positive_score

4 Weak

size

Size

annual sales of £25.4m, make it in line with the average company (£24.7m)

£25.4m - Orion Pharma (uk) Limited

£24.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (5.3%)

13% - Orion Pharma (uk) Limited

5.3% - Industry AVG

production

Production

with a gross margin of 40.8%, this company has a lower cost of product (29.5%)

40.8% - Orion Pharma (uk) Limited

29.5% - Industry AVG

profitability

Profitability

an operating margin of 5.8% make it more profitable than the average company (4.1%)

5.8% - Orion Pharma (uk) Limited

4.1% - Industry AVG

employees

Employees

with 48 employees, this is above the industry average (36)

48 - Orion Pharma (uk) Limited

36 - Industry AVG

paystructure

Pay Structure

on an average salary of £121.2k, the company has a higher pay structure (£81.8k)

£121.2k - Orion Pharma (uk) Limited

£81.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £528.9k, this is less efficient (£673.7k)

£528.9k - Orion Pharma (uk) Limited

£673.7k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 91 days, this is later than average (58 days)

91 days - Orion Pharma (uk) Limited

58 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 9 days, this is quicker than average (29 days)

9 days - Orion Pharma (uk) Limited

29 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Orion Pharma (uk) Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 22 weeks, this is more cash available to meet short term requirements (11 weeks)

22 weeks - Orion Pharma (uk) Limited

11 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 23.7%, this is a lower level of debt than the average (54%)

23.7% - Orion Pharma (uk) Limited

54% - Industry AVG

ORION PHARMA (UK) LIMITED financials

EXPORTms excel logo

Orion Pharma (Uk) Limited's latest turnover from December 2023 is £25.4 million and the company has net assets of £13.6 million. According to their latest financial statements, Orion Pharma (Uk) Limited has 48 employees and maintains cash reserves of £1.8 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover25,387,05022,240,12717,052,45917,811,32016,807,14817,935,12919,194,29719,369,96121,652,90523,826,32426,023,60427,309,24927,776,86025,419,51322,160,023
Other Income Or Grants000000000000000
Cost Of Sales15,017,42314,250,21511,032,04612,084,4829,832,45310,734,18612,775,74913,082,95314,856,16416,283,53317,634,34018,407,00718,895,31316,169,5410
Gross Profit10,369,6277,989,9126,020,4135,726,8386,974,6957,200,9436,418,5486,287,0086,796,7417,542,7918,389,2648,902,2428,881,5479,249,9720
Admin Expenses8,905,0746,844,8385,320,0504,916,7516,426,9197,014,6365,553,8554,938,3395,405,4434,661,4444,967,4525,137,1495,331,8344,517,322-5,373,987
Operating Profit1,464,5531,145,074700,363810,087547,776186,307864,6931,348,6691,391,2982,881,3473,421,8123,765,0933,549,7134,732,6505,373,987
Interest Payable0000000000200296910
Interest Receivable459,26055,91832,05095,711122,51575,33946,135132,387158,616123,413149,535358,558240,835149,198200,454
Pre-Tax Profit1,923,8131,200,992732,413905,798670,291261,646910,8281,481,0561,549,9143,004,7603,571,3454,123,6513,790,5484,881,5525,573,531
Tax-491,564-246,591-153,491-190,490-140,670-88,500-188,777-320,697-405,721-568,822-765,695-954,673-991,355-1,348,455508,404
Profit After Tax1,432,249954,401578,922715,308529,621173,146722,0511,160,3591,144,1932,435,9382,805,6503,168,9782,799,1933,533,0976,081,935
Dividends Paid4,000,0004,000,0004,000,000000000000000
Retained Profit-2,567,751-3,045,599-3,421,078715,308529,621173,146722,0511,160,3591,144,1932,435,9382,805,6503,168,9782,799,1933,533,0976,081,935
Employee Costs5,815,6784,864,2254,613,9324,303,3064,132,7314,175,7223,993,3073,839,2803,807,1513,795,9344,033,6614,202,2864,045,0994,018,9323,856,243
Number Of Employees485047464548484446475558596060
EBITDA*1,465,2381,154,127702,802814,089553,515193,226871,8321,353,9871,396,8942,894,9503,436,6073,780,3193,580,9404,790,3985,483,042

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets9711,6562,3414,7808,78214,52121,44027,22921,7429,14816,24830,66835,90644,18391,494
Intangible Assets92,049117,15447,930000000000000
Investments & Other0000007,101,8567,101,8567,101,8567,101,85600000
Debtors (Due After 1 year)000020,000,0000000000000
Total Fixed Assets93,020118,81050,2714,78020,008,78214,5217,123,2967,129,0857,123,5987,111,00416,24830,66835,90644,18391,494
Stock & work in progress000000000000000
Trade Debtors6,345,5294,655,5564,195,1323,379,7903,051,7133,492,3184,027,7864,061,1644,008,6654,589,8965,160,4875,485,3875,807,3285,194,1233,881,429
Group Debtors9,362,42611,705,999870,966721,654258,187292,476923,315768,95219,866,43418,674,46822,929,85320,255,01116,532,23714,393,3238,695,157
Misc Debtors169,639221,765259,268355,566375,907384,901474,579353,093245,701287,217367,302352,607458,2121,379,4692,622,707
Cash1,845,3562,432,07917,961,44522,424,1051,275,15729,526,91121,679,46521,786,2191,718,2731,111,6601,032,374683,253763,050576,281625,344
misc current assets000000000000000
total current assets17,722,95019,015,39923,286,81126,881,1154,960,96433,696,60627,105,14526,969,42825,839,07324,663,24129,490,01626,776,25823,560,82721,543,19615,824,637
total assets17,815,97019,134,20923,337,08226,885,89524,969,74633,711,12734,228,44134,098,51332,962,67131,774,24529,506,26426,806,92623,596,73321,587,37915,916,131
Bank overdraft000000000000000
Bank loan000000000000000
Trade Creditors 379,499233,305196,535280,06935,430135,138171,18183,59691,465104,11875,43386,649155,433211,396120,200
Group/Directors Accounts1,714,096453,9202,348,5772,609,812807,676362,9121,366,0191,406,4091,387,9831,498,2511,922,1281,789,9502,121,1533,136,8241,021,915
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities2,121,4962,340,3551,694,7421,521,2081,290,1421,434,2001,163,5101,802,8281,837,9021,670,7481,442,6331,654,3471,197,542900,187952,582
total current liabilities4,215,0913,027,5804,239,8544,411,0892,133,2481,932,2502,700,7103,292,8333,317,3503,273,1173,440,1943,530,9463,474,1284,248,4072,094,697
loans000000000000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000088016,44032,04347,60363,162
other liabilities000000000000000
provisions000000000000000
total long term liabilities000000000088016,44032,04347,60363,162
total liabilities4,215,0913,027,5804,239,8544,411,0892,133,2481,932,2502,700,7103,292,8333,317,3503,273,1173,441,0743,547,3863,506,1714,296,0102,157,859
net assets13,600,87916,106,62919,097,22822,474,80622,836,49831,778,87731,527,73130,805,68029,645,32128,501,12826,065,19023,259,54020,090,56217,291,36913,758,272
total shareholders funds13,600,87916,106,62919,097,22822,474,80622,836,49831,778,87731,527,73130,805,68029,645,32128,501,12826,065,19023,259,54020,090,56217,291,36913,758,272
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit1,464,5531,145,074700,363810,087547,776186,307864,6931,348,6691,391,2982,881,3473,421,8123,765,0933,549,7134,732,6505,373,987
Depreciation6859,0532,4394,0025,7396,9197,1395,3185,59613,60314,79515,22631,22757,748109,055
Amortisation000000000000000
Tax-491,564-246,591-153,491-190,490-140,670-88,500-188,777-320,697-405,721-568,822-765,695-954,673-991,355-1,348,455508,404
Stock000000000000000
Debtors-705,72611,257,954868,356-19,228,79719,516,112-1,255,985242,471-18,937,591569,219-4,906,0612,364,6373,295,2281,830,8625,767,62215,199,293
Creditors146,19436,770-83,534244,639-99,708-36,04387,585-7,869-12,65328,685-11,216-68,784-55,96391,196120,200
Accruals and Deferred Income-218,859645,613173,534231,066-144,058270,690-639,318-35,074167,154227,235-227,274441,202281,795-67,9541,015,744
Deferred Taxes & Provisions000000000000000
Cash flow from operations1,606,735-9,668,035-229,04520,328,101-19,347,0331,595,358-111,14919,927,938576,4557,488,10967,785-97,164984,555-2,302,437-8,071,903
Investing Activities
capital expenditure25,105-77,592-47,930000-1,350-10,805-18,190-6,503-375-9,988-22,950-10,437-200,549
Change in Investments00000-7,101,8560007,101,85600000
cash flow from investments25,105-77,592-47,930007,101,856-1,350-10,805-18,190-7,108,359-375-9,988-22,950-10,437-200,549
Financing Activities
Bank loans000000000000000
Group/Directors Accounts1,260,176-1,894,657-261,2351,802,136444,764-1,003,107-40,39018,426-110,268-423,877132,178-331,203-1,015,6712,114,9091,021,915
Other Short Term Loans 000000000000000
Long term loans000000000000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities000000000000000
share issue62,00155,00043,500-1,077,000-9,472,00078,000000000007,676,337
interest459,26055,91832,05095,711122,51575,33946,135132,387158,616123,413149,533358,558240,835148,902199,544
cash flow from financing1,781,437-1,783,739-185,685820,847-8,904,721-849,7685,745150,81348,348-300,464281,71127,355-774,8362,263,8118,897,796
cash and cash equivalents
cash-586,723-15,529,366-4,462,66021,148,948-28,251,7547,847,446-106,75420,067,946606,61379,286349,121-79,797186,769-49,063625,344
overdraft000000000000000
change in cash-586,723-15,529,366-4,462,66021,148,948-28,251,7547,847,446-106,75420,067,946606,61379,286349,121-79,797186,769-49,063625,344

orion pharma (uk) limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for orion pharma (uk) limited. Get real-time insights into orion pharma (uk) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Orion Pharma (uk) Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for orion pharma (uk) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other large companies, companies in EC3M area or any other competitors across 12 key performance metrics.

orion pharma (uk) limited Ownership

ORION PHARMA (UK) LIMITED group structure

Orion Pharma (Uk) Limited has no subsidiary companies.

Ultimate parent company

ORION CORP

#0025301

1 parent

ORION PHARMA (UK) LIMITED

02281057

ORION PHARMA (UK) LIMITED Shareholders

orion corporation 100%

orion pharma (uk) limited directors

Orion Pharma (Uk) Limited currently has 3 directors. The longest serving directors include Mr Olli Houtari (May 2007) and Dr Aino Hurme (Jan 2023).

officercountryagestartendrole
Mr Olli HoutariUnited Kingdom58 years May 2007- Director
Dr Aino HurmeFinland57 years Jan 2023- Director
Mr Rene LindellUnited Kingdom48 years Apr 2024- Director

P&L

December 2023

turnover

25.4m

+14%

operating profit

1.5m

+28%

gross margin

40.9%

+13.7%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

13.6m

-0.16%

total assets

17.8m

-0.07%

cash

1.8m

-0.24%

net assets

Total assets minus all liabilities

orion pharma (uk) limited company details

company number

02281057

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

July 1988

age

37

incorporated

UK

ultimate parent company

ORION CORP

accounts

Full Accounts

last accounts submitted

December 2023

previous names

deprenyl research limited (May 1995)

accountant

-

auditor

JAMES COWPER KRESTON AUDIT LLP

address

the scalpel, 18th floor, 52 lime street, london, EC3M 7AF

Bank

DANSKE BANK AS

Legal Advisor

CHARLES RUSSELL

orion pharma (uk) limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to orion pharma (uk) limited. Currently there are 2 open charges and 0 have been satisfied in the past.

orion pharma (uk) limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ORION PHARMA (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.

orion pharma (uk) limited Companies House Filings - See Documents

datedescriptionview/download